ZTEK

Zentek
ZTEK

$0.7500

1.35%

Market Cap: $78M

About: Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.

Employees: 27

0

Funds holding %

of 6,710 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

0.08% more ownership

Funds ownership: 0.93% [Q1] → 1.01% (+0.08%) [Q2]

0% more funds holding

Funds holding: 17 [Q1] → 17 (+0) [Q2]

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

11% less capital invested

Capital invested by funds: $1.23M [Q1] → $1.1M (-$129K) [Q2]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for ZTEK.

See Analyst Rankings

Financial journalist opinion

Zentek Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Guelph, Ontario--(Newsfile Corp. - September 13, 2024) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company") announces that on September 11, 2024, it received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), as the minimum bid price of the Company's common shares ("Shares") has been below US $1.00 per share for 31 consecutive business days.

Zentek Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Zentek Announces Closing of Non-Brokered Private Placement of Units

Guelph, Ontario--(Newsfile Corp. - August 19, 2024) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company"), an intellectual property development and commercialization company is pleased to announce that it has closed its non-brokered private placement of units (the "Units") through the issuance of 2,361,500 Units at a price of $1.30 per Unit (the "Offering") for gross proceeds of $3,069,950.

Zentek Announces Closing of Non-Brokered Private Placement of Units

Zentek Announces Upsize to Non-Brokered Private Placement of Units

Guelph, Ontario--(Newsfile Corp. - August 14, 2024) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company"), an intellectual property development and commercialization company is pleased to announce that, further to its press release of July 31, 2024, its previously announced non-brokered private placement of units (each, a "Unit") at a price of $1.30 per Unit has been upsized to 2,361,538 Units for aggregate gross proceeds of up to $3,070,000 (the "Offering").

Zentek Announces Upsize to Non-Brokered Private Placement of Units

Zentek Announces Normal Course Issuer Bid

GUELPH, ON / ACCESSWIRE / August 14, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN) wishes to announce that, subject to regulatory approval, it will conduct a normal course issuer bid (the "Bid").

Zentek Announces Normal Course Issuer Bid

Zentek Announces Preliminary Battery Results and University of Toronto Receives NSERC Mission Alliance Grant to Optimize Graphite for Battery Anode Use

GUELPH, ON / ACCESSWIRE / August 8, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is pleased to announce preliminary battery results and the commencement of a three-year, $441,000 project in collaboration with Professors Mohini Sain and Ning Yan from the University of Toronto ("U of T").

Zentek Announces Preliminary Battery Results and University of Toronto Receives NSERC Mission Alliance Grant to Optimize Graphite for Battery Anode Use

Zentek Launches National Sampling Program for ZenGUARD(TM) Antimicrobial Surgical Masks

GUELPH, ON / ACCESSWIRE / July 24, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company announces that it will embark on a Canada-wide sampling program for dental professionals facilitated by Henry Schein Inc. ("Henry Schein") that will see ZenGUARD™ Antimicrobial Surgical Masks included in product shipments to Henry Schein customers.

Zentek Launches National Sampling Program for ZenGUARD(TM) Antimicrobial Surgical Masks

Zentek Announces Non-Brokered Private Placement of Units for up to $3 Million

Guelph, Ontario--(Newsfile Corp. - July 23, 2024) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company"), an intellectual property development and commercialization company is pleased to announce its intention to complete a non-brokered private placement of up to $3 million through the issuance of up to 2,307,692 units (the "Units") in the capital of the Company at a price of $1.30 per Unit (the "Offering").

Zentek Announces Non-Brokered Private Placement of Units for up to $3 Million

Zentek Subsidiary Albany Graphite Corp. Achieves Five Nines Purity for Albany Graphite

GUELPH, ON / ACCESSWIRE / July 17, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company is pleased to announce that its wholly owned subsidiary, Albany Graphite Corporation (AGC) has achieved a five nines purity of 99.99915% for a graphite sample from the Albany graphite deposit.

Zentek Subsidiary Albany Graphite Corp. Achieves Five Nines Purity for Albany Graphite

Zentek Announces Grant of Stock Options

GUELPH, ON / ACCESSWIRE / June 21, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN) announces the granting of options to acquire an aggregate of 1,935,000 common shares to certain directors, officers and employees of the Company, exercisable at a price of $1.52 per common share for a period of five years from the date of the grant.

Zentek Announces Grant of Stock Options

Zentek Completes Case Study on HVAC Total Cost of Ownership Savings for the City of Toronto

GUELPH, ON / ACCESSWIRE / May 7, 2024 / Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company is pleased to announce that it has completed a case study based on the City of Toronto highlighting the economic and environmental benefits related to using MERV 9A filters compared to using MERV 13 filters.

Zentek Completes Case Study on HVAC Total Cost of Ownership Savings for the City of Toronto

See News Rankings